Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | PDE2A | O00408 | 8/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 1/20 | 0.34 |
| ▸ | MBOAT4 | Q96T53 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PDE1B | Q01064 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8519088 | 0.89 | ALDH1A1 (0.46) | SMN1; SMN2LMNAHTTRECQLALDH1A1 | |
| SCHEMBL4819202 | 0.89 | ALDH1A1 (0.46) | SMN1; SMN2LMNAHTTRECQLALDH1A1 | |
| SCHEMBL4817224 | 0.88 | ALDH1A1 (0.34) | SMN1; SMN2LMNAHTTALDH1A1KDM4E | |
| SCHEMBL3601556 | 0.86 | TSHR (0.39) | SMN1; SMN2LMNAHTTRECQLALDH1A1 | |
| SCHEMBL6188798 | 0.85 | SMN1; SMN2 (0.37) | SMN1; SMN2LMNAHTTRECQLALDH1A1 | |
| SCHEMBL4820368 | 0.85 | SMN1; SMN2 (0.39) | SMN1; SMN2LMNAHTTRECQLALDH1A1 | |
| SCHEMBL6188442 | 0.84 | PDE2A (0.39) | SMN1; SMN2LMNAHTTRECQLALDH1A1 | |
| SCHEMBL6186524 | 0.83 | PDE2A (0.39) | SMN1; SMN2LMNAHTTRECQLALDH1A1 | |
| SCHEMBL4818734 | 0.83 | ALDH1A1 (0.48) | SMN1; SMN2LMNAHTTRECQLALDH1A1 | |
| SCHEMBL6189796 | 0.81 | SMN1; SMN2 (0.41) | SMN1; SMN2LMNAALDH1A1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020068744-A1 | Substituted-triazolopyrimidines as anticancer agents | AMERICAN HOME PRODUCTS CORPORATION | 2002-06-06 | — | — | US | claimed |
| US-7329663-B2 | Substituted-triazolopyrimidines as anticancer agents | WYETH (US) | 2008-02-12 | — | — | US | disclosed |
| US-20020068744-A1 | Substituted-triazolopyrimidines as anticancer agents | AMERICAN HOME PRODUCTS CORPORATION | 2002-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020068744-A1 | Substituted-triazolopyrimidines as anticancer agents | TUBB3, TUBA1C, TUBB1 | SMN1; SMN2 655/4885LMNA 2723/4885HTT 830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.